Dandan Yu
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Oncology top 5%
Papers in
-
- Cancer, Hypoxia, and Metabolism 18
- MicroRNA in disease regulation 13
- Oncology 53
- Cancer Cells and Metastasis 9
- Co-authors
- Shanliang ZhongJinhai TangJianhua ZhaoWei‐xian ChenZhenyu LinLixin WeiYingying JingSu‐Jin Yang
- Journals
- Tumor Biology (10 papers)Acta Biochimica et Biophysica Sinica (9 papers)Scientific Reports (5 papers)Cancer Letters (5 papers)Oncotarget (5 papers)
- Partner nations
- ChinaNorwayUnited States
In The Last Decade
Dandan Yu
164 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 125
- Cancer Research 1.2k
- Oncology 780
- Molecular Biology 1.8k
- Hepatology 162
- Immunology 393
Countries citing papers authored by Dandan Yu
This map shows the geographic impact of Dandan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dandan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dandan Yu more than expected).
Fields of papers citing papers by Dandan Yu
This network shows the impact of papers produced by Dandan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dandan Yu. The network helps show where Dandan Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Dandan Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 17 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 13 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 4 | |
| 11 | 2022 | 6 | |
| 12 | 2021 | 41 | |
| 13 | 2019 | 18 | |
| 14 | 2018 | 19 | |
| 15 | 2017 | 1 | |
| 16 | 2015 | 38 | |
| 17 | 2014 | 101 | |
| 18 | 2014 | 1 | |
| 19 | 2013 | 2 | |
| 20 | Clinical Study of Guilu Erxianjiao Decoction in Treating Knee Osteoarthritis | 2005 | 2 |
About Dandan Yu
Dandan Yu is a scholar working on Cancer Research, Oncology, Molecular Biology, Hepatology and Hematology, having authored 169 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (18 papers), Gastric Cancer Management and Outcomes (13 papers), MicroRNA in disease regulation (13 papers), Circular RNAs in diseases (11 papers), Histone Deacetylase Inhibitors Research (10 papers), Multiple Myeloma Research and Treatments (10 papers), RNA modifications and cancer (9 papers) and Cancer Cells and Metastasis (9 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (780 citations), Molecular Biology (1.8k citations), Hepatology (162 citations) and Immunology (393 citations). Dandan Yu has collaborated with scholars based in China, Norway and United States. Frequent co-authors include Shanliang Zhong, Jinhai Tang, Jianhua Zhao, Wei‐xian Chen, Zhenyu Lin, Lixin Wei, Yingying Jing, Su‐Jin Yang, Ying Wu and Xiaohui Zhang. Their work appears in journals such as Tumor Biology, Acta Biochimica et Biophysica Sinica, Scientific Reports, Cancer Letters and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.